Cogent Biosciences Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama, I'm one of the Senior Biotech Analysts here at JPMorgan. I'm joined by my squad, Rati Pinge, Joyce Zhou and Priyanka Grover. Our first presenting company of the day is Cogent, and presenting on behalf of the company, we have CEO, Andy Robbins. Andy?
Great, Anupam. Thanks so much. Thanks for inviting us to the conference. We're happy to be here. My name is Andy Robbins; I'm the CEO of Cogent Biosciences. I'm going to do probably 20 minutes, 25 minutes of prepared remarks with a little presentation, and then maybe Anupam will ask some questions. We'll see if anybody in the audience has any questions. Before I get started, just to remind folks, I will be making some forward-looking statements. So we just tell you to take a look at our recent SEC filings for a full disclosure of all the risks associated with the company.
Okay. So as much
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
